Angela Lorenzi

Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone

Alessandro Corso, Angela Lorenzi, V. Terulla et al. · Annals of Hematology · 2004 · 71 citations

Medicine, Hematology, Pharmacology +13

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.

Alessandro Corso, Luca Arcaini, Silvia Mangiacavalli et al. · PubMed · 2001 · 49 citations

Medicine, Oncology, Pathology +17

Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications

Alessandro Corso, Patrizia Zappasodi, Cristiana Pascutto et al. · Annals of Hematology · 2003 · 25 citations

Medicine, Nephrology, Oncology +7

A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma.

Alessandro Corso, Luca Arcaini, Sabrina Caberlon et al. · PubMed · 2002 · 25 citations

Medicine, Hematology, Oncology +17

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels

Riccardo Moia, Donatella Talotta, Lodovico Terzi di Bergamo et al. · Blood Advances · 2025 · 16 citations · Full text

Medicine, Hematology, Oncology +17